These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 8164459)
1. [Blood donors with positive HBsAg in Asturias: its current prevalence and significance]. Suárez A; Riestra S; Navascués CA; Sotorrío NG; Rodríguez M; Tévar F; Pérez R; Sala P; Rodrigo L Med Clin (Barc); 1994 Mar; 102(9):329-32. PubMed ID: 8164459 [TBL] [Abstract][Full Text] [Related]
2. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias]. Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hepatitis B in Canadian blood donors. O'Brien SF; Xi G; Fan W; Yi QL; Fearon MA; Scalia V; Goldman M Transfusion; 2008 Nov; 48(11):2323-30. PubMed ID: 18647366 [TBL] [Abstract][Full Text] [Related]
4. [Hepatitis B and delta: the prevalence of seroepidemiological markers in volunteer blood donors and their families]. Alvarez-Muñoz MT; Bustamante-Calvillo ME; Guiscafré-Gallardo JP; Muñoz O Gac Med Mex; 1991; 127(5):399-404. PubMed ID: 1790848 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B surface and e antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Otegbayo JA; Fasola FA; Abja A Trop Gastroenterol; 2003; 24(4):196-7. PubMed ID: 15164531 [TBL] [Abstract][Full Text] [Related]
6. The decline of hepatitis B viral infection in South-Western Saudi Arabia. Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis B surface antigen (HBsAg) in blood donors from Bombay. Satoskar A; Ray V Trop Geogr Med; 1992 Jan; 44(1-2):119-21. PubMed ID: 1496703 [TBL] [Abstract][Full Text] [Related]
8. [Distribution characteristics of hepatitis B surface antigen positivity in Bursa]. Mistik R; Töre O; Kiliçturgay K Mikrobiyol Bul; 1991 Apr; 25(2):167-72. PubMed ID: 1745150 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. El Beltagy KE; Al Balawi IA; Almuneef M; Memish ZA Int J Infect Dis; 2008 Sep; 12(5):495-9. PubMed ID: 18400539 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of hepatitis B surface antigen (HBsAg) among drug-dependent patients in Jeddah, Saudi Arabia. Njoh J East Afr Med J; 1995 Mar; 72(3):198-9. PubMed ID: 7796776 [TBL] [Abstract][Full Text] [Related]
11. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil]. Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947 [TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. Amini S; Mahmoodi MF; Andalibi S; Solati AA J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302 [TBL] [Abstract][Full Text] [Related]
13. [A retrospective study of HBsAG carriers in the blood bank of Navarra]. Medarde A; del Hierro J; Aramburu E; Esquíroz P; Martínez JL Rev Med Univ Navarra; 1988; 32(4):209-16. PubMed ID: 3155332 [TBL] [Abstract][Full Text] [Related]
14. HBsAg carriers among blood donors in Italy; a retrospective survey of data from 189 blood banks. Giusti G; Galanti B; Gaeta GB; Piccinino F; Ruggiero G Hepatogastroenterology; 1981 Apr; 28(2):96-8. PubMed ID: 7216155 [TBL] [Abstract][Full Text] [Related]
15. Trend study on HBsAg prevalence in Thai voluntary blood donors. Tanprasert S; Somjitta S Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():43-5. PubMed ID: 7886604 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia. Vardas E; Sitas F; Seidel K; Casteling A; Sim J Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours. Alexopoulos CG; Vaslamatzis M; Hatzidimitriou G Br J Cancer; 1999 Sep; 81(1):69-74. PubMed ID: 10487614 [TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey. Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248 [TBL] [Abstract][Full Text] [Related]
19. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423 [TBL] [Abstract][Full Text] [Related]
20. Secular trend of age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. Lin HH; Kao JH; Chang TC; Hsu HY; Chen DS J Med Virol; 2003 Apr; 69(4):466-70. PubMed ID: 12601752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]